Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P2.18 - Poster Session 2 - Pathology
- Type: Poster Session
- Track: Pathology
- Presentations: 23
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.18-001 - Retrospective analysis of the clinico-pathological profile of ALK positive patients in the South of Spain (Andalusian Area)
09:30 - 09:30 | Author(s): J. Corral
- Abstract
Loading... -
+
P2.18-002 - A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations : frequent expression of epithelial-mesenchymal transition markers than other genotype
09:30 - 09:30 | Author(s): H. Kim
- Abstract
Loading... -
+
P2.18-003 - Spread Through Alveolar Spaces (STAS): A Newly Recognized Pattern of Invasion in Lung Adenocarcinoma Associated with Increased Recurrence in Patients Undergoing Limited Resection for ≤2cm Tumors
09:30 - 09:30 | Author(s): J. Nitadori
- Abstract
Loading... -
+
P2.18-004 - Clinical application of immunocytochemical detection of ALK rearrangement on cytology slides for detection or screening of lung adenocarcinoma
09:30 - 09:30 | Author(s): H. Tanaka
- Abstract
Loading... -
+
P2.18-005 - Morphological and genetic classification of lung cancer: variation in practice and implications for tailored treatment
09:30 - 09:30 | Author(s): J.R. Gosney
- Abstract
Loading... -
+
P2.18-006 - HER2 and BRAF mutations in non-small-cell lung cancer (NSCLC) patients (p).
09:30 - 09:30 | Author(s): A. Estival
- Abstract
Loading... -
+
P2.18-007 - Correlating Histologic and Molecular Features in the Lung Adenocarcinoma TCGA Project
09:30 - 09:30 | Author(s): W.D. Travis
- Abstract
Loading... -
+
P2.18-008 - Transformation to sarcomatoid carcinoma in ALK-rearranged adenocarcinoma which developed acquired resistance to crizotinib and received subsequent chemotherapies
09:30 - 09:30 | Author(s): Y. Kobayashi
- Abstract
Loading... -
+
P2.18-009 - Mutation Testing in Non-Small Cell Lung Cancer - Suitability of Small Biopsy and Cytology Specimens
09:30 - 09:30 | Author(s): S. Wang
- Abstract
Loading... -
+
P2.18-010 - Copy number changes in chromosome 2p are unique events among ALK fusion positive lung adenocarcinomas
09:30 - 09:30 | Author(s): H. Ninomiya
- Abstract
Loading... -
+
P2.18-011 - Bronchopulmonary carcinoid tumor (BPC) - is it time to change microscopic criteria of diagnosis?
09:30 - 09:30 | Author(s): R. Langfort
- Abstract
Loading... -
+
P2.18-012 - Bronchial washing/brushing samples are comparable to biopsy samples for EGFR mutation testing in non-small cell lung cancer
09:30 - 09:30 | Author(s): Y. Choi
- Abstract
Loading... -
+
P2.18-013 - Incidence of EGFR, KRAS, BRAF, ALK, and P53 alterations in a cohort of 159 consecutively tested patients from a certified lung cancer center, correlation with clinical characteristics and treatment outcome.
09:30 - 09:30 | Author(s): V. Halbfass
- Abstract
Loading... -
+
P2.18-014 - Impact of Non Small Cell Lung Cancer (NSCLC) immunophenotyping in chemotherapy response.
09:30 - 09:30 | Author(s): L. Righi
- Abstract
Loading... -
+
P2.18-015 - EGFR and KRAS mutational analysis using small amounts of DNA from FNA and small CNB is feasible and reproducible using a commercial real time PCR method. Validation of this PCR method in cytological samples.
09:30 - 09:30 | Author(s): M.D. Lozano
- Abstract
Loading... -
+
P2.18-016 - High throughput somatic mutation profiling in paraffin embedded Non-Small Cell Lung Cancer biopsies using the LungCarta™ Panel in clinical routine practice
09:30 - 09:30 | Author(s): A. Lemoine
- Abstract
Loading... -
+
P2.18-017 - Multiplexed-based mutation profiling of non small cell lung cancer small biopsy samples using the Sequenom LungCarta™ Panel and MassARRAY® System
09:30 - 09:30 | Author(s): A.M. Quinn
- Abstract
Loading... -
+
P2.18-018 - Outcomes of lung adenocarcinoma patients with signet ring cell tumors: a three-way evaluation
09:30 - 09:30 | Author(s): P. Yang
- Abstract
Loading... -
+
P2.18-019 - Clinicopathological features in non-small cell lung cancer patients with EGFR and KRAS mutations.
09:30 - 09:30 | Author(s): T. Nishii
- Abstract
Loading... -
+
P2.18-020 - Appropriateness Evaluation of Handling Method for the Small Lung Adenocarcinoma in the Frozen Section Diagnosis by Radiological-Pathological Correlation
09:30 - 09:30 | Author(s): T. Isaka
- Abstract
Loading... -
+
P2.18-021 - How Accurate are We in Diagnosing Squamous Cell Carcinoma of the Lung in Cytology Specimens and Relevance to Molecular Testing? An Institutional Experience.
09:30 - 09:30 | Author(s): R. Tondon
- Abstract
Loading... -
+
P2.18-022 - Do EGFR- and KRAS-mutations occur in squamous cell lung carcinomas?
09:30 - 09:30 | Author(s): J.P.L. Vincenten
- Abstract
Loading... -
+
P2.18-023 - Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced-disease non-small cell lung cancer.
09:30 - 09:30 | Author(s): A.D. Campos Parra
- Abstract
Loading...
-
+
P2.19 - Poster Session 2 - Imaging
- Type: Poster Session
- Track: Imaging, Staging & Screening
- Presentations: 14
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.19-001 - The Imaging Characteristics of F-18 FDG PET-CT on Epidermal Growth Factor Receptor Mutations in Non-small cell Lung Cancer
09:30 - 09:30 | Author(s): B.D. Polack
- Abstract
Loading... -
+
P2.19-002 - Pulmonary tularemia: a rare disease which can be mistaken for lung cancer
09:30 - 09:30 | Author(s): G. Hillerdal
- Abstract
Loading... -
+
P2.19-003 - A texture analysis approach to assess the severity of acute normal tissue changes in thoracic CT scans following radiation therapy for lung cancer
09:30 - 09:30 | Author(s): A. Cunliffe
- Abstract
Loading... -
+
P2.19-004 - Characterization of solitary pulmonary lesions combining visual perfusion and quantitative diffusion MR imaging
09:30 - 09:30 | Author(s): J.J. Coolen
- Abstract
Loading... -
+
P2.19-005 - Tumor growth rate of ground-glass nodules after long-term follow-up: The usefulness of a combination of initial computed tomography attenuation and tumor size as a predictor for tumor growth
09:30 - 09:30 | Author(s): T. Eguchi
- Abstract
Loading... -
+
P2.19-006 - Novel computed tomography windows for predicting pathological invasion area in pulmonary subsolid tumors
09:30 - 09:30 | Author(s): T. Eguchi
- Abstract
Loading... -
+
P2.19-007 - Pulmonary Nodule Detection by Junior Medical Staff is Improved by Digital Tomosynthesis Compared to Chest X-Ray
09:30 - 09:30 | Author(s): X. Lee
- Abstract
Loading... -
+
P2.19-008 - The prognostic value of tumor metabolic volume in PET-CT study for unresectable non-small-cell lung cancer treated with definite radiotherapy
09:30 - 09:30 | Author(s): M.J. Pelak
- Abstract
Loading... -
+
P2.19-009 - A Prediction Model to Estimate the Probability of Malignancy of Solitary Pulmonary Nodules Intergrating PET-CT and Clinical Data.
09:30 - 09:30 | Author(s): J. Liao
- Abstract
Loading... -
+
P2.19-010 - The association between baseline clinical-radiological characteristics and growth of pulmonary nodules with ground-glass opacity
09:30 - 09:30 | Author(s): Y. Kobayashi
- Abstract
Loading... -
+
P2.19-011 - Compensation of vital capacity of residual lobes after lung resection in patients with lung cancer
09:30 - 09:30 | Author(s): M. Matsutani
- Abstract
Loading... -
+
P2.19-012 - Inter-method Comparison of 18F-FDG PET Metabolic Response Assessment in Non-small Cell Lung Cancer
09:30 - 09:30 | Author(s): J. Wang
- Abstract
Loading... -
+
P2.19-013 - Pilot study of low dose computed tomography screening in first relative of lung cancer patient (preliminary report)
09:30 - 09:30 | Author(s): S. Saeteng
- Abstract
Loading... -
+
P2.19-014 - whole-body diffusion-weighted mri for staging non-small cell lung cancer patients
09:30 - 09:30 | Author(s): J.L. Gross
- Abstract
Loading...
-
+
P2.20 - Poster Session 2 - Early Detection and Screening
- Type: Poster Session
- Track: Imaging, Staging & Screening
- Presentations: 11
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.20-001 - Effect of repeated annual sputum cytology screening on high risk population: change of incidence of squamous cell carcinoma
09:30 - 09:30 | Author(s): A. Sakurada
- Abstract
Loading... -
+
P2.20-002 - Investigating suspected lung cancer: fast track in Stockholm
09:30 - 09:30 | Author(s): G. Hillerdal
- Abstract
Loading... -
+
P2.20-003 - Diagnostic work-up and surgery in participants of Gdansk lung cancer screening program - the extent of futile procedures in non-malignant condition
09:30 - 09:30 | Author(s): W. Rzyman
- Abstract
Loading... -
+
P2.20-004 - DNA copy number aberrations in endobronchial lesions: a validated predictor for cancer
09:30 - 09:30 | Author(s): R.A.A. Van Boerdonk
- Abstract
Loading... -
+
P2.20-005 - Volume Doubling Times of Subsolid Nodules Detected Using Low-dose CT Lung Cancer Screening based on an Eight-year Prospective Observation
09:30 - 09:30 | Author(s): R. Kakinuma
- Abstract
Loading... -
+
P2.20-006 - Autoantibodies to a panel of lung cancer-associated antigens can provide significant discrimination between malignant and non-malignant lung nodules
09:30 - 09:30 | Author(s): P.P. Massion
- Abstract
Loading... -
+
P2.20-007 - Computed Tomography (CT) Screening for Lung Cancer: Does the Mortality Endpoint Provide Definitive Evidence for CT Superiority in the National Lung Screening Trial (NLST)?
09:30 - 09:30 | Author(s): G.M. Strauss
- Abstract
Loading... -
+
P2.20-008 - Investigating symptoms of lung cancer: an evidence-based guide for general practitioners
09:30 - 09:30 | Author(s): L. Deutsch
- Abstract
Loading... -
+
P2.20-009 - Early detection of mediastinal tumors using low-dose spiral computed tomography.
09:30 - 09:30 | Author(s): I. Kasuga
- Abstract
Loading... -
+
P2.20-010 - Raman Spectroscopy Based Breath Analysis with Potential for Lung Cancer Detection
09:30 - 09:30 | Author(s): K.K. Chow
- Abstract
Loading... -
+
P2.20-011 - A prospective clinical study evaluating stage dependent sputum micro-RNA expression profiles for the detection of non-small cell lung cancer
09:30 - 09:30 | Author(s): R. Razzak
- Abstract
Loading...
-
+
P2.21 - Poster Session 2 - Diagnosis and Staging
- Type: Poster Session
- Track: Prevention & Epidemiology
- Presentations: 11
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.21-001 - Solitary pulmonary squamous cell carcinoma in patients with a history of squamous cell carcinoma: metastasis or second primary tumour?
09:30 - 09:30 | Author(s): T. Murakawa
- Abstract
Loading... -
+
P2.21-002 - Identification of Malignant Pleural Effusions (MPEs) secondary to lung cancer by tumour markers: a national multi-centre trial
09:30 - 09:30 | Author(s): S. Elia
- Abstract
Loading... -
+
P2.21-003 - The relationship between the type of bone metastasis and EGFR gene mutation in non-small cell lung cancer
09:30 - 09:30 | Author(s): K. Akanabe
- Abstract
Loading... -
+
P2.21-004 - Infrared spectral cytopathology of the respiratory tract:
a pilot study09:30 - 09:30 | Author(s): J. Brown
- Abstract
Loading... -
+
P2.21-005 - Non-Small Cell Lung Cancer (NSCLC) in the United States Department of Defense
09:30 - 09:30 | Author(s): C.A. Carter
- Abstract
Loading... -
+
P2.21-006 - Molecular analysis of liquid based cytological samples by bronchoscopy in lung cancer patients
09:30 - 09:30 | Author(s): Y. Nakamura
- Abstract
Loading... -
+
P2.21-007 - Computed tomography-guided needle aspiration and biopsy of pulmonary lesions: a single-center experience on 750 biopsies in Japan
09:30 - 09:30 | Author(s): J. Takeshita
- Abstract
Loading... -
+
P2.21-008 - Clinical and Epidemiologic Study of ALK Fusion Genes in Lung Cancer Patients in Latin America: challenges and perspectives
09:30 - 09:30 | Author(s): C. Baldotto
- Abstract
Loading... -
+
P2.21-009 - Results of Epidermal Growth Factor Receptor (EGFR) Reflex Testing implementation in the Brazilian National Cancer Institute (INCA)
09:30 - 09:30 | Author(s): C. Baldotto
- Abstract
Loading... -
+
P2.21-010 - EGFR mutation frequency in patients diagnosed with NSCLC from Costa Rica
09:30 - 09:30 | Author(s): L. Corrales-Rodriguez
- Abstract
Loading... -
+
P2.21-011 - Persistent Ground-Glass Opacity Lung Nodules < 20 mm in Diameter at CT: Histopathologic Comparisons with imaging features
09:30 - 09:30 | Author(s): L. Yang
- Abstract
Loading...
-
+
P2.22 - Poster Session 2 - Epidemiology, Etiology
- Type: Poster Session
- Track: Prevention & Epidemiology
- Presentations: 13
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.22-001 - Japanese Nation Wide Lung Cancer Registries conducted by the Japanese Joint Committee of Lung Cancer Registry (JJCLCR)
09:30 - 09:30 | Author(s): N. Sawabata
- Abstract
Loading... -
+
P2.22-002 - Study of Some Factors Related to Epidemiology In Malignant Pleural Mesothelioma
09:30 - 09:30 | Author(s): N.S. Lam
- Abstract
Loading... -
+
P2.22-003 - BIM (BCL2L11) deletion polymorphism is one of major risk factors of Lung cancer in Korean population.
09:30 - 09:30 | Author(s): E.N. Cho
- Abstract
Loading... -
+
P2.22-004 - Survival improvement in primary lung cancer patients in a 10-year period: results of the French KBP-2000-CPHG and KBP-2010-CPHG cohorts
09:30 - 09:30 | Author(s): C. Locher
- Abstract
Loading... -
+
P2.22-005 - Clinicopathologic Characteristics of Lung Cancer Associated with Pleural Plaques
09:30 - 09:30 | Author(s): R. Sugimoto
- Abstract
Loading... -
+
P2.22-006 - Retrospective analysis of non small cell lung cancer patients submitted to ressection or radiosurgery for brain metastasis (BM) at Brazilian National Cancer Institute
09:30 - 09:30 | Author(s): C. Baldotto
- Abstract
Loading... -
+
P2.22-007 - Survival Advancements In Advanced Non-Small Cell Lung Cancer In The Past 20 Years: A Story of Hope
09:30 - 09:30 | Author(s): A. Ravelo
- Abstract
Loading... -
+
P2.22-008 - Analysis of family history of cancer in women with lung cancer (WLC) from the Spanish WORLD07 database
09:30 - 09:30 | Author(s): M. Majem
- Abstract
Loading... -
+
P2.22-009 - Quality in lung cancer care: The development of a population based lung cancer registry
09:30 - 09:30 | Author(s): R. Stirling
- Abstract
Loading... -
+
P2.22-010 - The Incidence, Treatment and Survival of Lung Cancer in a Regional Australian Cancer Centre from 2006 to 2011.
09:30 - 09:30 | Author(s): A. Jones
- Abstract
Loading... -
+
P2.22-011 - Racial/Ethnic Variation Among Non-Small Cell Lung Cancer (NSCLC) Patients in the United States Department of Defense
09:30 - 09:30 | Author(s): C.A. Carter
- Abstract
Loading... -
+
P2.22-012 - Worse survival outcomes in patients with lung cancer from deprived areas of residence in Scotland: Why?
09:30 - 09:30 | Author(s): M.C. Nicolson
- Abstract
Loading... -
+
P2.22-013 - Evaluation of elderly patients with non-small-cell lung cancer in a private Cancer Center in Brazil.
09:30 - 09:30 | Author(s): T. Montella
- Abstract
Loading...
-
+
P2.23 - Poster Session 2 - Tobacco Control, Prevention and Chemoprevention
- Type: Poster Session
- Track: Prevention & Epidemiology
- Presentations: 2
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.23-001 - Does dissatisfaction with body image in adolescents a determinant of smoking behavior?
09:30 - 09:30 | Author(s): H.C. Queiroga
- Abstract
Loading... -
+
P2.23-002 - Protecting from second hand smoke: An assessment of SHS exposure in public places in two states of India
09:30 - 09:30 | Author(s): U. Kaushik
- Abstract
Loading...
-
+
P2.24 - Poster Session 2 - Supportive Care
- Type: Poster Session
- Track: Supportive Care
- Presentations: 61
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.24-001 - Lung cancer in rural and remote Aboriginal and Torres Strait Islander communities in Queensland
09:30 - 09:30 | Author(s): B.J. Page
- Abstract
Loading... -
+
P2.24-002 - Tolerability and barriers to delivery of adjuvant Cisplatin/Vinorelbine chemotherapy in non small cell lung cancer
09:30 - 09:30 | Author(s): A. Jebb
- Abstract
Loading... -
+
P2.24-003 - Third-line therapy and beyond for patients with advanced/metastatic non-small cell lung cancer (NSCLC)
09:30 - 09:30 | Author(s): J. Corral
- Abstract
Loading... -
+
P2.24-004 - Chest Wall toxicity following SABR for early lung cancer: A dosimetric analysis.
09:30 - 09:30 | Author(s): P. Jain
- Abstract
Loading... -
+
P2.24-005 - Oral EGFR TKIs as first line treatment for NSCLC: experience from a tertiary care centre in North India
09:30 - 09:30 | Author(s): D. Behera
- Abstract
Loading... -
+
P2.24-006 - Bronchial associated lymphoid tissue (BALT) lymphoma - Is Rituximab alone a viable option instead of aggressive local therapy and high dose chemotherapy even in the relapsed setting for this rather rare entity?
09:30 - 09:30 | Author(s): R. Sunkara
- Abstract
Loading... -
+
P2.24-007 - First-line Pemetrexed plus Cisplatin followed by maintenance Pemetrexed vs Carboplatin-Paclitaxel plus Bevacizumab followed by maintenance Bevacizumab (ERACLE) in advanced non squamous non-small Cell Lung Cancer : a Quality of Life-oriented, multicenter randomized phase III trial of the GOIM (Gruppo Oncologico Italia Meridionale).
09:30 - 09:30 | Author(s): D. Galetta
- Abstract
Loading... -
+
P2.24-008 - eviQ - a web based, point of care treatment resource - its role in lung cancer
09:30 - 09:30 | Author(s): L. King
- Abstract
Loading... -
+
P2.24-009 - Atypical CT findings in a patient with a BRAF V600E mutated pulmonary Langerhans cell histiocytosis (PLCH)
09:30 - 09:30 | Author(s): E. Willenbacher
- Abstract
Loading... -
+
P2.24-010 - Advanced non small lung cancer long term survivors - clinical data analysis. Single center experience
09:30 - 09:30 | Author(s): E. Chmielowska
- Abstract
Loading... -
+
P2.24-011 - Left Ventricular Thormbosis due to Chemotherapy using Bevacizumab for Lung Cancer.
09:30 - 09:30 | Author(s): K. Yanagihara
- Abstract
Loading... -
+
P2.24-012 - Public Attitudes about Lung Cancer: Stigma, Support, and Predictors of Support
09:30 - 09:30 | Author(s): J. Weiss
- Abstract
Loading... -
+
P2.24-013 - Efficacy and safety of erlotinib in Croatian patients
09:30 - 09:30 | Author(s): M. Jakopovic
- Abstract
Loading... -
+
P2.24-014 - Primary Lung Cancer Coexisting with Lung Metastases from Other Malignancies
09:30 - 09:30 | Author(s): N. Nishiyama
- Abstract
Loading... -
+
P2.24-015 - The role of WALCE (Women Against Lung Cancer in Europe) in helping patients and their caregivers to cope with cancer.
09:30 - 09:30 | Author(s): S. Vallone
- Abstract
Loading... -
+
P2.24-016 - Why do we treat lung cancer patients with chemotherapy until the end of life?
09:30 - 09:30 | Author(s): F.C. Lopes
- Abstract
Loading... -
+
P2.24-017 - 5 cases of long-term survival in posterior spinal fixation surgery against vertebral metastasis of lung cancer
09:30 - 09:30 | Author(s): T. Igarashi
- Abstract
Loading... -
+
P2.24-018 - Primary mediastinal Castleman' disease; Surgically curable anemia : A case report
09:30 - 09:30 | Author(s): S.Y. Choi
- Abstract
Loading... -
+
P2.24-019 - Pleurodesis with bleomycin in advanced non small cell lung cancer: A single centre experience from Southern India
09:30 - 09:30 | Author(s): K. Rathnam
- Abstract
Loading... -
+
P2.24-020 - Uk Lung Cancer Survival: Where are we going wrong?
09:30 - 09:30 | Author(s): H. Wilson
- Abstract
Loading... -
+
P2.24-021 - Adjuvant or Induction chemotherapy for Non Small Cell Lung Cancer treated with chemoradiotherapy: An invidual data metaanalysis of phase II trials
09:30 - 09:30 | Author(s): P. Van Houtte
- Abstract
Loading... -
+
P2.24-022 - Implementing Dyspnea Management: A quality improvement project for patients with lung cancer in Ontario, Canada
09:30 - 09:30 | Author(s): Y.C. Ung
- Abstract
Loading... -
+
P2.24-023 - A descriptive pilot study to evaluate the current practices of determining "Do Not Resuscitate Status" in patients with incurable lung cancer at Cancer Care Manitoba, Canada.
09:30 - 09:30 | Author(s): N. Ahmed
- Abstract
Loading... -
+
P2.24-024 - Metabolic activity on [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression may predict clinical outcomes in patients with limited disease of small cell lung cancer receiving concurrent chemoradiation
09:30 - 09:30 | Author(s): J. Lee
- Abstract
Loading... -
+
P2.24-025 - Applying the results of the FRAGMATIC trial to real life: longitudinal qualitative study exploring the experiences of patients partcipating in a randomised Phase III clinical trial investigating the effect of FRAGMin Added To standard therapy In lung Cancer
09:30 - 09:30 | Author(s): S. Noble
- Abstract
Loading... -
+
P2.24-026 - Lung cancer pathway at the Royal Adelaide Hospital: Impact of treatment intent and patient location.
09:30 - 09:30 | Author(s): J.R. Ng
- Abstract
Loading... -
+
P2.24-027 - Cisplatin plus pemetrexed and concurrent radiation with consecutive surgery in locally advanced adenocarcinoma of the right lung - case report
09:30 - 09:30 | Author(s): M. Zemanova
- Abstract
Loading... -
+
P2.24-028 - Photodynamic Therapy for Airway Malignancies: A 15-year single institution experience
09:30 - 09:30 | Author(s): P. Ross
- Abstract
Loading... -
+
P2.24-029 - Patterns of palliative care involvement in metastatic non-small cell lung cancer patients: Limitations of early palliative care in a rural Australian centre
09:30 - 09:30 | Author(s): A. Prawira
- Abstract
Loading... -
+
P2.24-030 - Increasing Therapeutic Efficacy and Safety of Docetaxel in Lung Cancer
09:30 - 09:30 | Author(s): G.S. Bhattacharyya
- Abstract
Loading... -
+
P2.24-031 - Pre-treatment symptom profiles predict survival in patients with non-small cell lung cancer
09:30 - 09:30 | Author(s): M. Chen
- Abstract
Loading... -
+
P2.24-032 - Bronchoscopy in the Czech Republic, 2012
09:30 - 09:30 | Author(s): M. Marel
- Abstract
Loading... -
+
P2.24-033 - The value of assessing muscle depletion in lung cancer (sarcopenia) rather than body surface area, in the work-up to chemotherapy. Reflections from a Systematic Review.
09:30 - 09:30 | Author(s): J. Collins
- Abstract
Loading... -
+
P2.24-034 - Treatment Beyond Progression in Patients with Non-Small Cell Lung Cancer Harbouring EGFR Mutations - The Manchester Lung Cancer Group Experience
09:30 - 09:30 | Author(s): E. Halkyard
- Abstract
Loading... -
+
P2.24-035 - Description of lung cancer patients with ECOG 2 at diagnosis. Experience of our Hospital
09:30 - 09:30 | Author(s): A. Artal
- Abstract
Loading... -
+
P2.24-036 - Erlotinib in metastatic, EGFR wild-type, Non-Small Cell Lung Cancer (NSCLC) as second or further line of therapy.
09:30 - 09:30 | Author(s): A. Hernández
- Abstract
Loading... -
+
P2.24-037 - Feasibility of creative art therapy as a supportive care modality for patients with metastatic lung cancer treated with chemotherapy
09:30 - 09:30 | Author(s): B. Etienne-Mastroianni
- Abstract
Loading... -
+
P2.24-038 - Lung cancer and combined pulmonary fibrosis and emphysema syndrome in Western patients: a series of 47 patients
09:30 - 09:30 | Author(s): N. Girard
- Abstract
Loading... -
+
P2.24-039 - Renal failure is the first cause of double maintenance (bevacizumab + pemetrexed) discontinuation for toxicity in real world setting
09:30 - 09:30 | Author(s): M. Sassier
- Abstract
Loading... -
+
P2.24-040 - Analysis of why certain respiratory cancer patients diagnosed and/or receiving cancer directed treatment have repeat presentations at Multidisciplinary Team Meetings.
09:30 - 09:30 | Author(s): S. Dunn
- Abstract
Loading... -
+
P2.24-041 - A Pilot study of a Steroid Sulphatase inhibitor (BN83495) in patients with rash due to treatment with an oral epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) for non-small cell lung cancer (NSCLC)
09:30 - 09:30 | Author(s): L. Mileshkin
- Abstract
Loading... -
+
P2.24-042 - Role of comorbidity on survival after radio- and chemotherapy for non-surgically treated lung cancer
09:30 - 09:30 | Author(s): A. Mellemgaard
- Abstract
Loading... -
+
P2.24-043 - Developing an optimal best practice model of care for the management of lung cancer in Australia: a national approach
09:30 - 09:30 | Author(s): E. King
- Abstract
Loading... -
+
P2.24-044 - Use and comparison of erythropoiesis-stimulating agents (ESAs) for the treatment of chemotherapy-induced anaemia (CIA) in patients with non-small cell lung cancer (NSCLC)
09:30 - 09:30 | Author(s): A. Rodriguez Garzotto
- Abstract
Loading... -
+
P2.24-045 - Enhancing psychological services for people with lung cancer
09:30 - 09:30 | Author(s): M. Ftanou
- Abstract
Loading... -
+
P2.24-046 - Quality of Life in Patients With Malignant Pleural Effusion Undergoing Pleurodesi
09:30 - 09:30 | Author(s): R.M. Terra
- Abstract
Loading... -
+
P2.24-047 - Palliative Care Units in the management of patients with advanced lung cancer - the experience of the Medical University of Vienna
09:30 - 09:30 | Author(s): S. Schur
- Abstract
Loading... -
+
P2.24-048 - Prevalence of pulmonary embolism in patients with oncogene addicted advanced lung adenocarcinoma
09:30 - 09:30 | Author(s): L. Crino
- Abstract
Loading... -
+
P2.24-049 - The significance of fever after the first administration of zoledronate as a prognostic factor in patients with advanced non-small cell lung cancer.
09:30 - 09:30 | Author(s): H. Izumi
- Abstract
Loading... -
+
P2.24-050 - Treatment pathways of patients diagnosed with non-small cell lung cancer - an audit of practice at a regional teaching hospital.
09:30 - 09:30 | Author(s): C.J. Hunter
- Abstract
Loading... -
+
P2.24-051 - Cicatricial Fibromatosis with High SUV were Suspected by a Local Recurrence of Bronchial Stump in Patient with Lung Cancer
09:30 - 09:30 | Author(s): Y.S. Yoon
- Abstract
Loading... -
+
P2.24-052 - A Single Centre Review of Endothelial Growth Factor Receptor (EGFR) Mutation Testing: A Regional Australian Experience.
09:30 - 09:30 | Author(s): S. Twaddell
- Abstract
Loading... -
+
P2.24-053 - 11-Year Survival of a Patient with Untreated, EGFR Positive, Pulmonary Adenocarcinoma
09:30 - 09:30 | Author(s): N.C. Kahn
- Abstract
Loading... -
+
P2.24-054 - Relationship Between Distress Level and Survival Rate Among Newly Diagnosed Stage IV Non-Small Cell Lung Cancer (NSCLC): Pilot Study
09:30 - 09:30 | Author(s): C.D. Bergerot
- Abstract
Loading... -
+
P2.24-055 - ReaLCaRe: Recovery after lung resection. Study design and preliminary results.
09:30 - 09:30 | Author(s): J.G. Timmerman
- Abstract
Loading... -
+
P2.24-056 - A Tertiary cancer experience in use of TKI in metastatic lung cancer
09:30 - 09:30 | Author(s): V. Naronha
- Abstract
Loading... -
+
P2.24-057 - Stereotactic Body Radiation Therapy (SBRT) - The success of a new technique in a complex clinical case
09:30 - 09:30 | Author(s): A.R. Figueredo
- Abstract
Loading... -
+
P2.24-058 - Thoracic Multidisciplinary Meeting Discussion Outcomes at Auckland City Hospital: Concordance with Actual Patient Management for Lung Malignancies
09:30 - 09:30 | Author(s): L. Cossar
- Abstract
Loading... -
+
P2.24-059 - Results of treating advanced stage non small cell lung cancer by erlotinib at the Pulmonary Department, Cho Ray hospital: first vietnamese case report
09:30 - 09:30 | Author(s): L.T. Vu
- Abstract
Loading... -
+
P2.24-060 - VATS lobectomy using subcostal incision in NSCLC
09:30 - 09:30 | Author(s): J. Hwang
- Abstract
Loading... -
+
P2.24-061 - Profiling Hospital Performance: Adherence to Guidelines for Perioperative Lung Cancer Imaging
09:30 - 09:30 | Author(s): L. Backhus
- Abstract
Loading...
-
+
P2.25 - Poster Session 2 - Nurses
- Type: Poster Session
- Track: Nurses
- Presentations: 2
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.25-001 - Workflow improvement and results of standardization of thoracic surgery procedures among six hospitals
09:30 - 09:30 | Author(s): Y. Iwasaki
- Abstract
Loading... -
+
P2.25-002 - How do patients with lung cancer experience radiation induced oesophagitis?
09:30 - 09:30 | Author(s): M. Duffy
- Abstract
Loading...
-
+
Best of Posters - IASLC Selection - Part 1
- Type: Exhibit Showcase Session
- Track:
- Presentations: 4
- Coordinates: 10/29/2013, 09:55 - 10:25, Exhibit Hall, Ground Level
-
+
DISCUSSION
10:10 - 10:25
- Abstract
No abstract available for this presentation
-
+
P1.11-008 - A phase II study of HSP90 inhibitor AUY922 and erlotinib (E) in patients (pts) with EGFR-mutant lung cancer and acquired resistance (AR) to EGFR tyrosine kinase inhibitors (EGFR TKIs).
09:55 - 10:00 | Author(s): H.A. Yu
- Abstract
Loading... -
+
P1.11-032 - Results with dacomitinib (PF-00299804), an irreversible pan-HER tyrosine kinase inhibitor, in a phase II cohort of patients with HER2-mutant or amplified lung cancers
10:00 - 10:05 | Author(s): M.G. Kris
- Abstract
Loading... -
+
P2.11-035 - Association of tumor PD-L1 expression and immune biomarkers with clinical activity in patients with non-small cell lung cancer (NSCLC) treated with nivolumab (Anti-PD-1; BMS-936558; ONO-4538)
10:05 - 10:10 | Author(s): S.J. Antonia
- Abstract
Loading...
-
+
GR02 - Is There a Role for the Thoracic Oncology Nurse in Ensuring Patients with an Advanced Lung Cancer have Access to Early Phase Clinical Trials?
- Type: Grand Round Session
- Track: Nurses
- Presentations: 6
- Moderators:C. Broderick
- Coordinates: 10/29/2013, 10:30 - 12:00, Bayside Gallery A, Level 1
-
+
GR02.0 - N/A - Chair Intro
10:30 - 10:35 | Author(s): M. Culligan
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
GR02.1 - Affirmative
10:35 - 10:50 | Author(s): P. Yates
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
GR02.2 - Affirmative
10:50 - 11:05 | Author(s): J. White
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
GR02.3 - Negative
11:05 - 11:20 | Author(s): M. Culligan
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
GR02.4 - Negative
11:20 - 11:35 | Author(s): Y. Lai
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
GR02.5 - Discussion
11:35 - 12:00 | Author(s): N. n/a
- Abstract
No abstract available for this presentation
first
prev
